[go: up one dir, main page]

CN112684093A - A kind of quality detection method of eleven prescription medicinal wine - Google Patents

A kind of quality detection method of eleven prescription medicinal wine Download PDF

Info

Publication number
CN112684093A
CN112684093A CN202011445271.XA CN202011445271A CN112684093A CN 112684093 A CN112684093 A CN 112684093A CN 202011445271 A CN202011445271 A CN 202011445271A CN 112684093 A CN112684093 A CN 112684093A
Authority
CN
China
Prior art keywords
solution
medicinal liquor
acetonitrile
eleven
party
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011445271.XA
Other languages
Chinese (zh)
Other versions
CN112684093B (en
Inventor
田慧
马雯芳
潘小姣
刘舒玲
毛德文
邱华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University of Chinese Medicine
Original Assignee
Guangxi University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University of Chinese Medicine filed Critical Guangxi University of Chinese Medicine
Priority to CN202011445271.XA priority Critical patent/CN112684093B/en
Publication of CN112684093A publication Critical patent/CN112684093A/en
Application granted granted Critical
Publication of CN112684093B publication Critical patent/CN112684093B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a quality detection method of eleven-prescription medicinal liquor, belonging to the technical field of quality detection of medicines. The invention firstly identifies three components of dragon's blood, angelica and rhizoma paridis in the medicinal liquor of the first ten prescription by using a thin-layer chromatography, and carries out qualitative analysis on the components; and then, the contents of the hydroxysafflor yellow A and the loureirin B in the medicinal liquor of the first ten are simultaneously detected by utilizing the high performance liquid chromatography, quantitative analysis is carried out, the operation condition is simple and easy to implement, and the detection result is accurate and feasible by adopting the conditions of the thin layer chromatography and the high performance liquid chromatography. The quality detection method of the invention has the advantages of stability, reliability, strong specificity and good reproducibility, and combines qualitative and quantitative analysis to ensure that the quality control and detection of the eleven-party medicinal liquor are safer and more effective.

Description

Quality detection method of eleven-prescription medicinal liquor
Technical Field
The invention belongs to the technical field of quality detection of medicines, and particularly relates to a quality detection method of eleven-prescription medicinal liquor.
Background
The ten-prescription medicinal liquor is a preparation which is independently researched and developed by Guangxi Chinese medicinal university and is worthy of being saved and has determined curative effect, and consists of multiple Chinese medicaments such as rhizoma paridis, pseudo-ginseng, safflower, calcined native copper, frankincense, large-leaved gentian, myrrh, teasel root, rhubarb, nux vomica and the like.
However, the previous quality control only involves the measurement of the components such as nux vomica, pseudo-ginseng, teasel root and the like, but no quality detection method suitable for the contents of the three components such as dragon's blood, angelica and rhizoma paridis, as well as the contents of hydroxysafflor yellow A and loureirin B exists, and an efficient and accurate detection method is urgently needed for further ensuring the stability and the curative effect of the medicinal liquor of the first ten prescriptions.
Disclosure of Invention
Aiming at the problems, the invention provides a quality detection method of eleven-party medicinal liquor, which is characterized in that three components of dragon's blood, angelica and rhizoma paridis in the eleven-party medicinal liquor are firstly identified by thin-layer chromatography for qualitative analysis; and simultaneously detecting the contents of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the tenth party by using a high performance liquid chromatography, and carrying out quantitative analysis, thereby ensuring the stability and effectiveness of the medicinal liquor of the tenth party.
The invention is realized by the following technical scheme:
a quality detection method of eleven-prescription medicinal liquor comprises the following steps:
carrying out qualitative analysis on three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor by using a thin-layer chromatography;
detecting the content of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by using a high performance liquid chromatography.
In the qualitative analysis of the components, the dracaena cochinchinensis, the angelica and the rhizoma paridis in the ten-party medicinal liquor are respectively extracted by n-butyl alcohol, ethyl ether and ethyl acetate.
As a further preferred aspect of the present invention, the thin layer chromatography further comprises a developing solvent, wherein the developing solvent used for the three components of the dragon's blood, the angelica and the rhizoma paridis is sequentially: the mixed solution of n-hexane-ethyl acetate-methanol with the volume ratio of 20-25:8-10:1, the mixed solution of toluene-acetone-ammonia water with the volume ratio of 1-3:1-4:0.2-0.5, and the lower layer solution of chloroform-ethyl acetate-methanol-water with the volume ratio of 8-10:15-20:8-15: 3.
As a further preferred aspect of the present invention, the high performance liquid chromatography comprises:
when the content of the hydroxysafflor yellow A is detected, octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 285-one 403nm, the flow rate is 1.0mL/min, the column temperature is 20-30 ℃, the hydroxysafflor yellow A reference solution, the eleventh formula medicinal liquor test solution and the negative reference solution are respectively subjected to gradient elution to obtain a hydroxysafflor yellow A reference chromatogram and an eleventh formula medicinal liquor test chromatogram, and the content of the hydroxysafflor yellow A is determined by calculating the corresponding peak area in the eleven formula medicinal liquor test chromatogram;
when the content of the loureirin B is detected, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 255-280nm, the flow rate is 1.0mL/min, the column temperature is 20-30 ℃, gradient elution is respectively carried out on loureirin B reference substance solution, eleven-party medicinal liquor test solution and negative reference solution, a loureirin B reference substance chromatogram and an eleven-party medicinal liquor test solution chromatogram are obtained, and the content of the loureirin B is determined by calculating the corresponding peak appearance area in the eleven-party medicinal liquor test solution chromatogram.
As a further preferred aspect of the present invention, the gradient elution specifically comprises:
detecting hydroxy safflower yellow A content in 10-20% acetonitrile for 0-10 min; 10-15min, 20-26% acetonitrile; 15-20min, 26% acetonitrile; 20-30min, 26-35% acetonitrile; 30-40min, 35-20% acetonitrile.
Detecting the content of loureirin B with 20% acetonitrile for 0-10 min; 10-15min, 20-30% acetonitrile; 15-20min, 30% acetonitrile; 20-30min, 30-38% acetonitrile; 30-40min, 38-30% acetonitrile.
Compared with the prior art, the invention has the advantages and beneficial effects that:
1. the invention firstly identifies three components of dragon's blood, angelica and rhizoma paridis in the medicinal liquor of the first ten prescription by using a thin-layer chromatography for qualitative analysis; and then, the contents of the hydroxysafflor yellow A and the loureirin B in the medicinal liquor of the first ten are simultaneously detected by utilizing the high performance liquid chromatography, quantitative analysis is carried out, the operation condition is simple and easy to implement, and the detection result is accurate and feasible by adopting the conditions of the thin layer chromatography and the high performance liquid chromatography. The quality detection method of the invention has the advantages of stability, reliability, strong specificity and good reproducibility, and the qualitative and quantitative analysis of the invention is combined to lay a foundation for establishing the quality standard of the eleven-prescription medicinal liquor.
2. The method of the invention can effectively control the quality of the eleven medicinal liquor, is beneficial to stabilizing the quality of the product, ensures the safety and effectiveness of medication and better meets the requirements of medical treatment and market by identifying three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor and detecting the contents of hydroxy safflower yellow A and dracaolin B in the eleven medicinal liquor.
Drawings
FIG. 1 is a thin-layer chromatogram of sanguis Draxonis, in which: 1 represents a dragon blood reference substance, 2 represents a dragon blood reference medicinal material, 3 represents a dragon blood test sample, and 4 represents a negative reference substance.
FIG. 2 is a thin layer chromatogram of Angelica sinensis, in which: 1 represents angelica sinensis control medicinal materials, 2 represents eleven-party medicinal liquor, and 3 represents angelica sinensis negative control.
Fig. 3 is a thin layer chromatogram of rhizoma paridis, in which: 1 represents the paris polyphylla reference medicinal material, 2 represents the paris polyphylla sample, and 3 represents the paris polyphylla negative control.
FIG. 4 is a chromatogram of hydroxysafflor yellow A reference and an eleventh medicinal wine sample.
FIG. 5 is a chromatogram of a loureirin B reference substance and an eleven-ingredient medicinal liquor test sample.
Detailed Description
The present invention is further illustrated by the following examples, which are provided only for illustrating the present invention and are not intended to limit the scope of the present invention.
A quality detection method of eleven-prescription medicinal liquor comprises qualitatively analyzing three components of sanguis Draxonis, radix Angelicae sinensis, and rhizoma paridis in eleven-prescription medicinal liquor by thin layer chromatography; and detecting the contents of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by using a high performance liquid chromatography for quantitative analysis.
Example 1
The qualitative analysis of three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor by using the thin-layer chromatography comprises the following steps:
(1) identifying dragon's blood by thin-layer chromatography:
1) preparing a test solution: taking 50mL of a ten-party medicinal liquor, shaking and extracting with saturated n-butyl alcohol for 3 times, 50mL each time, combining n-butyl alcohol extracts, washing with an ammonia water test solution for 3 times, 50mL each time, discarding an alkali solution, combining n-butyl alcohol solutions, washing with water saturated n-butyl alcohol until the solution is neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of absolute ethyl alcohol into residues to dissolve and fix the volume to 5mL, and taking the residues as a test sample solution;
2) negative control solution preparation: taking 50mL of a sample prepared from a dragon blood medicinal material, shaking and extracting with water-saturated n-butyl alcohol for 3 times, 50mL each time, combining n-butyl alcohol extracts, washing with ammonia water for 3 times, 50mL each time, discarding an alkali solution, combining n-butyl alcohol solutions, washing with water-saturated n-butyl alcohol until the solution is neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of absolute ethyl alcohol into residues to dissolve and fix the volume to 5mL, and taking the residues as a negative control solution;
3) preparation of a reference solution: taking a loureirin B reference substance, adding absolute ethyl alcohol to prepare a solution containing 1mg of loureirin B per 1mL, and taking the solution as a reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), spreading with mixed solution of n-hexane-ethyl acetate-methanol at volume ratio of 20:8:1 as developing agent, spreading to span 8cm, taking out, air drying, fumigating in ammonia vapor for 15min, and inspecting in sunlight. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference. The results are shown in FIG. 1.
(2) Identification of angelica by thin-layer chromatography:
1) preparing a test solution: taking 30mL of eleven-prescription medicinal liquor, extracting with diethyl ether for 3 times, 20mL each time, discarding the diethyl ether layer, extracting the aqueous solution with water-saturated n-butanol for 3 times, 20mL each time, combining the extracts, washing with water-saturated n-butanol to neutrality, evaporating the n-butanol solution to dryness, adding 2mL of methanol into the residue to dissolve and fix the volume to 5mL to obtain a sample solution;
2) negative control solution preparation: extracting 30mL of a sample prepared from a Chinese angelica medicinal material with diethyl ether for 3 times, 20mL each time, discarding a diethyl ether layer, extracting an aqueous solution with water-saturated n-butyl alcohol for 3 times, 20mL each time, combining extract liquor, washing with water-saturated n-butyl alcohol to be neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of methanol into residues to dissolve the residues and fixing the volume to 5mL to serve as a negative control solution;
3) preparation of a reference solution: taking ferulic acid reference substance, adding anhydrous alcohol to make into solution containing 1mg of loureirin B per 1mL as reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), applying round spotting, developing with toluene-acetone-ammonia water as developing agent at volume ratio of 1:1:0.2, spreading at a distance of 8cm, taking out, air drying, blowing off solvent with cold air until no ammonia smell is generated, and spray-developing with bismuth potassium iodide test solution. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference. The results are shown in FIG. 2.
(3) Identifying rhizoma paridis by thin-layer chromatography:
1) preparing a test solution: collecting 30mL of the eleven-prescription medicinal liquor, extracting with ethyl acetate for 3 times with shaking, 30mL each time, mixing the ethyl acetate extractive solutions, evaporating to dryness, adding 2mL of anhydrous ethanol into the residue to dissolve, and diluting to a constant volume of 5mL to obtain a sample solution;
2) negative control solution preparation: taking 30mL of a sample prepared from the rhizoma paridis medicinal material, extracting with ethyl acetate for 3 times with shaking, 30mL each time, combining ethyl acetate extracting solutions, evaporating to dryness, adding 2mL of absolute ethanol into residues to dissolve and fix the volume to 5mL, and taking the residue as a negative control solution;
3) preparation of a reference solution: taking a rhizoma paridis saponin A reference substance, and adding anhydrous ethanol to obtain a solution containing 1mg of rhizoma paridis saponin A per 1mL as a reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), applying round spotting with lower layer solution of chloroform-ethyl acetate-methanol-water at volume ratio of 8:15:8:3 as developing agent, spreading for 8cm, taking out, air drying, spraying 5% ethanol sulfate solution, and heating at 110 deg.C for 5min until spots are clear. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference. The results are shown in FIG. 3.
Example 2
The qualitative analysis of three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor by using the thin-layer chromatography comprises the following steps:
(1) identifying dragon's blood by thin-layer chromatography:
1) preparing a test solution: collecting 30mL of the eleven-prescription medicinal liquor, shaking and extracting with saturated n-butyl alcohol for 3 times, 30mL each time, combining n-butyl alcohol extracts, washing with ammonia water test solution for 2 times, 30mL each time, discarding alkali liquor, combining n-butyl alcohol solutions, washing with water saturated n-butyl alcohol until neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of methanol into residues to dissolve and fix the volume to 5mL, and taking the residues as a test sample solution;
2) negative control solution preparation: taking 30mL of a sample prepared from a dragon blood medicinal material, shaking and extracting with water-saturated n-butyl alcohol for 3 times, 30mL each time, combining n-butyl alcohol extracts, washing with ammonia water for 3 times, 30mL each time, discarding an alkali solution, combining n-butyl alcohol solutions, washing with water-saturated n-butyl alcohol until the solution is neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of methanol into residues to dissolve and fix the volume to 5mL, and taking the residues as a negative control solution;
3) preparation of a reference solution: adding methanol into loureirin B reference substance to obtain 1mg loureirin B solution per 1mL as reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), spreading with mixed solution of n-hexane-ethyl acetate-methanol at volume ratio of 25:10:1 as developing agent, spreading at a distance of 8cm, taking out, air drying, fumigating in ammonia vapor for 20min, and inspecting in sunlight. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference.
(2) Identification of angelica by thin-layer chromatography:
1) preparing a test solution: taking 30mL of eleven-prescription medicinal liquor, extracting with diethyl ether for 3 times, 20mL each time, discarding the diethyl ether layer, extracting the aqueous solution with water-saturated n-butanol for 3 times, 20mL each time, combining the extracts, washing with water-saturated n-butanol to neutrality, evaporating the n-butanol solution to dryness, adding 2mL of methanol into the residue to dissolve and fix the volume to 5mL to obtain a sample solution;
2) negative control solution preparation: extracting 30mL of a sample prepared from a Chinese angelica medicinal material with diethyl ether for 3 times, 20mL each time, discarding a diethyl ether layer, extracting an aqueous solution with water-saturated n-butyl alcohol for 3 times, 20mL each time, combining extract liquor, washing with water-saturated n-butyl alcohol to be neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of methanol into residues to dissolve the residues and fixing the volume to 5mL to serve as a negative control solution;
3) preparation of a reference solution: taking ferulic acid reference substance, adding anhydrous alcohol to make into solution containing 1mg of loureirin B per 1mL as reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), applying round spotting, developing with toluene-acetone-ammonia water as developing agent at volume ratio of 3:4:0.5, spreading at a distance of 8cm, taking out, air drying, blowing off solvent with cold air until no ammonia smell is generated, and spray-developing with bismuth potassium iodide test solution. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference.
(3) Identifying rhizoma paridis by thin-layer chromatography:
1) preparing a test solution: collecting 30mL of the eleven-prescription medicinal liquor, extracting with ethyl acetate for 3 times with shaking, 30mL each time, mixing the ethyl acetate extractive solutions, evaporating to dryness, adding 2mL of anhydrous ethanol into the residue to dissolve, and diluting to a constant volume of 5mL to obtain a sample solution;
2) negative control solution preparation: taking 30mL of a sample prepared from the rhizoma paridis medicinal material, extracting with ethyl acetate for 3 times with shaking, 30mL each time, combining ethyl acetate extracting solutions, evaporating to dryness, adding 2mL of absolute ethanol into residues to dissolve and fix the volume to 5mL, and taking the residue as a negative control solution;
3) preparation of a reference solution: taking a rhizoma paridis saponin A reference substance, and adding anhydrous ethanol to obtain a solution containing 1mg of rhizoma paridis saponin A per 1mL as a reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), applying round spotting with lower layer solution of chloroform-ethyl acetate-methanol-water at volume ratio of 10:20:15:3 as developing agent, spreading for 8cm, taking out, air drying, spraying 5% ethanol sulfate solution, and heating at 110 deg.C for 5min until spots are clear. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference.
Example 3
Simultaneously detecting the contents of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by utilizing a high performance liquid chromatography, and carrying out quantitative analysis, wherein the quantitative analysis comprises the following steps:
(1) detecting hydroxysafflor yellow A by high performance liquid chromatography:
1) chromatographic conditions are as follows: octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 403nm, the flow rate is 1.0mL/min, the column temperature is 30 ℃, and gradient elution is carried out;
TABLE 1 gradient elution Table
Figure BDA0002824161250000061
2) Preparation of a reference solution: taking a proper amount of a reference substance of the hydroxysafflor yellow A, precisely weighing, adding methanol to prepare a solution of the hydroxysafflor yellow A with the component mass concentration of 420 mu g/mL, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain a reference substance solution of the hydroxysafflor yellow A;
3) preparing a test solution: precisely measuring 5mL of a ten-party medicinal liquor, evaporating to dryness in a water bath, adding 30mL of hot water, dissolving for 3 times, transferring to a separating funnel, adding 10mL of diethyl ether, extracting for 1 time, standing, removing a diethyl ether layer, extracting a water layer with water-saturated n-butyl alcohol for 2 times, each time with 10mL, mixing n-butyl alcohol, washing with water-saturated n-butyl alcohol for 2 times, each time with 30mL, evaporating the n-butyl alcohol layer to dryness in a water bath, adding a methanol solution into residues, fixing the volume to a 10mL measuring flask, shaking uniformly, filtering through a 0.45-micrometer microporous membrane, and taking a subsequent filtrate to;
4) negative control solution preparation: taking 5mL of a sample prepared from safflower, evaporating to dryness in a water bath, adding 30mL of hot water, dissolving for 3 times, transferring to a separating funnel, adding 10mL of diethyl ether, extracting for 1 time, standing, removing a diethyl ether layer, extracting a water layer for 2 times by using water saturated n-butyl alcohol, extracting for 10mL each time, combining n-butyl alcohol, washing n-butyl alcohol saturated ammonia test solution for 2 times, evaporating to dryness in a water bath of the n-butyl alcohol layer, adding a methanol solution into residues, fixing the volume to a 10mL measuring flask, shaking up, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain the safflower extract;
5) and (3) determination: precisely sucking 10 μ L of the mixed reference solution, the sample solution, and the negative reference solution, respectively, injecting into a liquid chromatograph, and measuring. The results are shown in FIG. 4, and the content of hydroxysafflor yellow A is determined by calculating the corresponding peak area in the chromatogram of the test sample of the eleven medicinal liquors.
(2) Detecting loureirin B by high performance liquid chromatography:
1) chromatographic conditions are as follows: octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 285nm, the flow rate is 1.0mL/min, the column temperature is 30 ℃, and gradient elution is carried out;
TABLE 2 gradient elution Table
Figure BDA0002824161250000071
2) Preparation of a reference solution: taking a proper amount of loureirin B reference substance, precisely weighing, adding methanol to prepare a loureirin B solution with the component mass concentration of 124 mu g/mL, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain a loureirin B reference substance solution;
3) preparing a test solution: precisely measuring 5mL of thirteen-party medicinal liquor, evaporating to dryness in a water bath, adding 0.5% hydrochloric acid, dissolving for 3 times, 10mL each time, filtering, adding 2mL of concentrated ammonia water into the filtrate to adjust the pH to 8, extracting for 3 times by using n-hexane, adding a methanol solution into the residue, metering the volume to a 10mL measuring flask, shaking up, filtering through a 0.45-micrometer microporous membrane, and taking the subsequent filtrate to obtain the medicinal liquor;
4) negative control solution preparation: taking 5mL of a sample prepared from safflower, evaporating to dryness in a water bath, adding 0.5% hydrochloric acid, dissolving for 3 times, 10mL each time, filtering, adding 2mL of concentrated ammonia water into the filtrate to adjust the pH value to 8, extracting for 3 times by using n-hexane, adding a methanol solution into the residue, fixing the volume to a 10mL measuring flask, shaking up, filtering through a 0.45-micrometer microporous membrane, and taking a subsequent filtrate to obtain the safflower extract;
5) and (3) determination: precisely sucking 10 μ L of the mixed reference solution, the sample solution, and the negative reference solution, respectively, injecting into a liquid chromatograph, and measuring. The result is shown in figure 5, and the content of the loureirin B is determined by calculating the corresponding peak area in the chromatogram of the test sample of the eleven medicinal liquor.
Example 4
Simultaneously detecting the contents of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by utilizing a high performance liquid chromatography, and carrying out quantitative analysis, wherein the quantitative analysis comprises the following steps:
(1) detecting hydroxysafflor yellow A by high performance liquid chromatography:
1) chromatographic conditions are as follows: octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 285nm, the flow rate is 1.0mL/min, the column temperature is 20 ℃, and gradient elution is carried out;
TABLE 1 gradient elution Table
Figure BDA0002824161250000081
2) Preparation of a reference solution: taking a proper amount of a reference substance of the hydroxysafflor yellow A, precisely weighing, adding methanol to prepare a solution of the hydroxysafflor yellow A with the component mass concentration of 420 mu g/mL, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain a reference substance solution of the hydroxysafflor yellow A;
3) preparing a test solution: precisely measuring 5mL of a ten-party medicinal liquor, evaporating to dryness in a water bath, adding 30mL of hot water, dissolving for 3 times, transferring to a separating funnel, adding 10mL of diethyl ether, extracting for 1 time, standing, removing a diethyl ether layer, extracting a water layer with water-saturated n-butyl alcohol for 2 times, each time with 10mL, mixing n-butyl alcohol, washing with water-saturated n-butyl alcohol for 2 times, each time with 30mL, evaporating the n-butyl alcohol layer to dryness in a water bath, adding a methanol solution into residues, fixing the volume to a 10mL measuring flask, shaking uniformly, filtering through a 0.45-micrometer microporous membrane, and taking a subsequent filtrate to;
4) negative control solution preparation: taking 5mL of a sample prepared from safflower, evaporating to dryness in a water bath, adding 30mL of hot water, dissolving for 3 times, transferring to a separating funnel, adding 10mL of diethyl ether, extracting for 1 time, standing, removing a diethyl ether layer, extracting a water layer for 2 times by using water saturated n-butyl alcohol, extracting for 10mL each time, combining n-butyl alcohol, washing n-butyl alcohol saturated ammonia test solution for 2 times, evaporating to dryness in a water bath of the n-butyl alcohol layer, adding a methanol solution into residues, fixing the volume to a 10mL measuring flask, shaking up, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain the safflower extract;
5) and (3) determination: precisely sucking 10 μ L of the mixed reference solution, the sample solution, and the negative reference solution, respectively, injecting into a liquid chromatograph, and measuring. And determining the content of hydroxysafflor yellow A by calculating the corresponding peak area in the chromatogram of the test sample of the eleven medicinal liquor.
(2) Detecting loureirin B by high performance liquid chromatography:
1) chromatographic conditions are as follows: octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 255nm, the flow rate is 1.0mL/min, the column temperature is 20 ℃, and gradient elution is carried out;
TABLE 2 gradient elution Table
Figure BDA0002824161250000091
2) Preparation of a reference solution: taking a proper amount of loureirin B reference substance, precisely weighing, adding methanol to prepare a loureirin B solution with the component mass concentration of 124 mu g/mL, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain a loureirin B reference substance solution;
3) preparing a test solution: precisely measuring 5mL of thirteen-party medicinal liquor, evaporating to dryness in a water bath, adding 0.5% hydrochloric acid, dissolving for 3 times, 10mL each time, filtering, adding 2mL of concentrated ammonia water into the filtrate to adjust the pH to 8, extracting for 3 times by using n-hexane, adding a methanol solution into the residue, metering the volume to a 10mL measuring flask, shaking up, filtering through a 0.45-micrometer microporous membrane, and taking the subsequent filtrate to obtain the medicinal liquor;
4) negative control solution preparation: taking 5mL of a sample prepared from safflower, evaporating to dryness in a water bath, adding 0.5% hydrochloric acid, dissolving for 3 times, 10mL each time, filtering, adding 2mL of concentrated ammonia water into the filtrate to adjust the pH value to 8, extracting for 3 times by using n-hexane, adding a methanol solution into the residue, fixing the volume to a 10mL measuring flask, shaking up, filtering through a 0.45-micrometer microporous membrane, and taking a subsequent filtrate to obtain the safflower extract;
5) and (3) determination: precisely sucking 10 μ L of the mixed reference solution, the sample solution, and the negative reference solution, respectively, injecting into a liquid chromatograph, and measuring. And determining the content of loureirin B by calculating the corresponding peak area in the chromatogram of the test sample of the eleven medicinal liquor.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and the like that are within the spirit and principle of the present invention are included in the present invention.

Claims (5)

1. A quality detection method of eleven-prescription medicinal liquor is characterized by comprising the following steps:
carrying out qualitative analysis on three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor by using a thin-layer chromatography;
detecting the content of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by using a high performance liquid chromatography.
2. The method for detecting the quality of the ten-party medicinal liquor according to claim 1, wherein in the qualitative analysis of the components, the dragon's blood, the angelica and the rhizoma paridis in the ten-party medicinal liquor are respectively extracted by n-butanol, diethyl ether and ethyl acetate.
3. The method for detecting the quality of the eleven-ingredient medicinal liquor according to claim 2, wherein a developing solvent is further used in the thin layer chromatography, and the developing solvents used for the three components of the dragon's blood, the Chinese angelica and the paris polyphylla are sequentially as follows: the mixed solution of n-hexane-ethyl acetate-methanol with the volume ratio of 20-25:8-10:1, the mixed solution of toluene-acetone-ammonia water with the volume ratio of 1-3:1-4:0.2-0.5, and the lower layer solution of chloroform-ethyl acetate-methanol-water with the volume ratio of 8-10:15-20:8-15: 3.
4. The quality detection method of the ten-party medicinal liquor according to any one of claims 1 to 3, characterized in that the high performance liquid chromatography is respectively as follows:
when the content of the hydroxysafflor yellow A is detected, octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 285-one 403nm, the flow rate is 1.0mL/min, the column temperature is 20-30 ℃, the hydroxysafflor yellow A reference solution, the eleventh formula medicinal liquor test solution and the negative reference solution are respectively subjected to gradient elution to obtain a hydroxysafflor yellow A reference chromatogram and an eleventh formula medicinal liquor test chromatogram, and the content of the hydroxysafflor yellow A is determined by calculating the corresponding peak area in the eleven formula medicinal liquor test chromatogram;
when the content of the loureirin B is detected, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 255-280nm, the flow rate is 1.0mL/min, the column temperature is 20-30 ℃, gradient elution is respectively carried out on loureirin B reference substance solution, eleven-party medicinal liquor test solution and negative reference solution, a loureirin B reference substance chromatogram and an eleven-party medicinal liquor test solution chromatogram are obtained, and the content of the loureirin B is determined by calculating the corresponding peak appearance area in the eleven-party medicinal liquor test solution chromatogram.
5. The quality detection method of the ten-party medicinal liquor according to claim 4, wherein the gradient elution is specifically as follows:
detecting hydroxy safflower yellow A content in 10-20% acetonitrile for 0-10 min; 10-15min, 20-26% acetonitrile; 15-20min, 26% acetonitrile; 20-30min, 26-35% acetonitrile; 30-40min, 35-20% acetonitrile.
Detecting the content of loureirin B with 20% acetonitrile for 0-10 min; 10-15min, 20-30% acetonitrile; 15-20min, 30% acetonitrile; 20-30min, 30-38% acetonitrile; 30-40min, 38-30% acetonitrile.
CN202011445271.XA 2020-12-08 2020-12-08 A quality detection method for eleven prescription medicinal wine Active CN112684093B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011445271.XA CN112684093B (en) 2020-12-08 2020-12-08 A quality detection method for eleven prescription medicinal wine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011445271.XA CN112684093B (en) 2020-12-08 2020-12-08 A quality detection method for eleven prescription medicinal wine

Publications (2)

Publication Number Publication Date
CN112684093A true CN112684093A (en) 2021-04-20
CN112684093B CN112684093B (en) 2022-11-25

Family

ID=75448799

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011445271.XA Active CN112684093B (en) 2020-12-08 2020-12-08 A quality detection method for eleven prescription medicinal wine

Country Status (1)

Country Link
CN (1) CN112684093B (en)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607693A (en) * 1991-03-14 1997-03-04 Lvmh Recherche Cosmetic or pharmaceutical composition, especially dermatological composition, containing oxyacanthine, intended in particular for stimulating hair growth or retarding hair loss
JP2001270835A (en) * 2000-03-15 2001-10-02 Korea Yakult Co Ltd Extract of perilla frutescens var. acuta kudo effective for prophylaxis and therapy of gastric ulcer, its use and process for obtaining berberine from the extract
CN1384357A (en) * 2002-05-30 2002-12-11 云南白药集团天然药物研究院 Gongxuening capsule quality determining method
CN1712953A (en) * 2005-06-13 2005-12-28 昆明滇虹药业有限公司 Quality control detection method of dragon's blood
CN1850095A (en) * 2006-02-22 2006-10-25 天津大学 Use of chonglou saponin compound
CN101057925A (en) * 2007-06-01 2007-10-24 湖南金沙药业股份有限公司 Preparation technology for 'jieguqili' capsule and its quality control method
CN101648005A (en) * 2008-08-13 2010-02-17 北京和润创新医药科技发展有限公司 Medicinal composition for treating skin injury and ulcer and application thereof
CN101780189A (en) * 2009-01-20 2010-07-21 江苏康缘药业股份有限公司 Method for controlling quality of Resina Draconis drug
WO2012152044A1 (en) * 2011-05-11 2012-11-15 西安千禾药业有限责任公司 A method for detecting a haemostasis medicine
CN104840967A (en) * 2015-05-13 2015-08-19 上海中医药大学 Taste correction method for oral liquid preparation of traditional Chinese medicine containing ethyl alcohol
CN108553461A (en) * 2018-01-06 2018-09-21 张恒源 A kind of cold compress gel and preparation method thereof for treating newborn diapers dermatitis

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607693A (en) * 1991-03-14 1997-03-04 Lvmh Recherche Cosmetic or pharmaceutical composition, especially dermatological composition, containing oxyacanthine, intended in particular for stimulating hair growth or retarding hair loss
JP2001270835A (en) * 2000-03-15 2001-10-02 Korea Yakult Co Ltd Extract of perilla frutescens var. acuta kudo effective for prophylaxis and therapy of gastric ulcer, its use and process for obtaining berberine from the extract
CN1384357A (en) * 2002-05-30 2002-12-11 云南白药集团天然药物研究院 Gongxuening capsule quality determining method
CN1712953A (en) * 2005-06-13 2005-12-28 昆明滇虹药业有限公司 Quality control detection method of dragon's blood
CN1850095A (en) * 2006-02-22 2006-10-25 天津大学 Use of chonglou saponin compound
CN101057925A (en) * 2007-06-01 2007-10-24 湖南金沙药业股份有限公司 Preparation technology for 'jieguqili' capsule and its quality control method
CN101648005A (en) * 2008-08-13 2010-02-17 北京和润创新医药科技发展有限公司 Medicinal composition for treating skin injury and ulcer and application thereof
CN101780189A (en) * 2009-01-20 2010-07-21 江苏康缘药业股份有限公司 Method for controlling quality of Resina Draconis drug
WO2012152044A1 (en) * 2011-05-11 2012-11-15 西安千禾药业有限责任公司 A method for detecting a haemostasis medicine
CN104840967A (en) * 2015-05-13 2015-08-19 上海中医药大学 Taste correction method for oral liquid preparation of traditional Chinese medicine containing ethyl alcohol
CN108553461A (en) * 2018-01-06 2018-09-21 张恒源 A kind of cold compress gel and preparation method thereof for treating newborn diapers dermatitis

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
刘永忠 等: "重楼分散片的制备和质量分析", 《南昌大学学报(理科版)》 *
刘玉珍 等: "保心宁胶囊质量标准的研究", 《中成药》 *
姚苗苗 等: "RP-HPLC法同时测定红花中羟基红花黄色素A与红花黄色素A的含量", 《药物分析杂志》 *
王常顺: "无敌药酒与无敌丹胶囊质量控制方法研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 *
郝永龙 等: "活血伸筋搽剂的薄层色谱鉴别", 《山东中医杂志》 *

Also Published As

Publication number Publication date
CN112684093B (en) 2022-11-25

Similar Documents

Publication Publication Date Title
CN111044624B (en) Quality detection method of Chinese medicinal preparation
CN102998411B (en) A kind of detection method of ageratum dripping pill
CN103197027A (en) Quality control method of astragalus-leech capsules capable of regulating collaterals
CN101028388B (en) Quality inspection of Chinese-medicinal preparation for treating shortsighness and asthenopia
CN108037200B (en) A kind of quality detection method of Zishen Ningshen pill
CN113484429B (en) Method for establishing standard of peach pit qi-bearing soup material
CN106290644A (en) A kind of quality determining method treating erysipelas medicine
CN102879516A (en) Method for identifying Buyang Huanwu soup and measuring content of Buyang Huanwu soup
CN117665191B (en) Method for detecting quality of effective components in known cellulitis particles
CN101385808B (en) The detection method of Juper Anshendan
CN112684093A (en) A kind of quality detection method of eleven prescription medicinal wine
CN114441685B (en) Paris polyphylla standard decoction quality detection method
CN110716002A (en) Quality control method of shiwei ginseng-angelica enema liquid
CN107576749A (en) A kind of detection method of rheumatic cold pain piece
CN101987154B (en) Thin-layer chromatographic detection method for cornel in gynecological recovery pills
CN101461860A (en) Method for controlling quality of Chinese medicine liquid preparation
CN101112424B (en) Asthma tablet detection method
CN105486763B (en) A kind of quality determining method of female clever ball and its application
CN102809626A (en) Quality control method of Qianshan Huoxue plaster
CN103076403A (en) Quality inspection method for capsule for treating lower urinary tract infection
CN102078363A (en) Detection method for humifuse euphorbia herb traditional Chinese medicine preparation
CN113567577A (en) Thin-layer identification and high performance liquid chromatography detection method for index components in Shenshuai Yifang granules
CN113533613B (en) Method for identifying specific components in liver soothing granules
CN113295816B (en) Thin layer chromatography detection method for Yihechun preparation
CN114324726B (en) Thin-layer chromatography detection method of kidney-nourishing and fetus-nourishing pill

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant